A case of exacerbation of subclinical hyperthyroidism after first administration of bnt162b2 mrna covid-19 vaccine

20Citations
Citations of this article
44Readers
Mendeley users who have this article in their library.

Abstract

COVID-19 vaccines are the most critical measure for controlling the COVID-19 pandemic; however, we have little information on their complications. We experienced a case of a patient who developed hyperthyroidism complicated with atrial fibrillation and heart failure on the sixth day after the first dose of COVID-19 vaccination. This case report shows the importance of considering hyperthyroidism as a possible complication after COVID-19 vaccination.

Cite

CITATION STYLE

APA

Yamamoto, K., Mashiba, T., Takano, K., Suzuki, T., Kami, M., Takita, M., … Hamaki, T. (2021). A case of exacerbation of subclinical hyperthyroidism after first administration of bnt162b2 mrna covid-19 vaccine. Vaccines, 9(10). https://doi.org/10.3390/vaccines9101108

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free